Trials / Unknown
UnknownNCT03629769
Effects of Proxelan Somministration in Patients With Chronic Prostatitis
Effects of Proxelan Somministration in Patients With Chronic Prostatitis Cat. IIa NIH: Pilot Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Pisa · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Proxelan | Administration of one suppository of proxelan once a day for 30 days |
Timeline
- Start date
- 2017-02-16
- Primary completion
- 2018-09-01
- Completion
- 2018-09-30
- First posted
- 2018-08-14
- Last updated
- 2018-08-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03629769. Inclusion in this directory is not an endorsement.